Dy. Maeda et al., Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors, J MED CHEM, 43(21), 2000, pp. 3941-3948
To develop affinity labels for delta opioid receptors based on peptide anta
gonists, the Phe(4) residues of N,N-dibenzylleucine enkephalin and N,N-dial
lyl[Aib(2),Aib(3)]leucine enkephalin (ICI-174,864) were substituted with ei
ther Phe(p-NCS) or Phe(p-NHCOCH2Br). A general synthetic method was develop
ed for the conversion of small peptide substrates into potential affinity l
abels. The target peptides were synthesized using Phe(p-NH2) and a Boc/Fmoc
orthogonal protection strategy which allowed for late functional group con
version of a p-amine group in the peptides to the desired affinity labeling
moieties. A key step in the synthesis was the selective deprotection of a
Boc group in the presence of a tert-butyl ester using trimethylsilyl triflu
oromethanesulfonate (TMS-OTf). The target peptides were evaluated in radiol
igand binding experiments in Chinese hamster ovary (CHO) cells expressing d
elta or mu opioid receptors. The delta receptor affinities of the N,N-diben
zylleucine enkephalin analogues were 2.5-10-fold higher than those for the
corresponding ICI-174,864 analogues. In general, substitution at the para p
osition of Phe(4) decreased binding affinity at both delta and mu receptors
in standard radioligand binding assays; the one exception was N,N-dibenzyl
[Phe(p-NCS)(4)]leucine enkephalin (2) which exhibited a 2-fold increase in
affinity for delta receptors (IC50 = 34.9 nM) compared to N,N-dibenzylleuci
ne enkephalin (IC50 = 78.2 nM). The decreases in mu receptor affinities wer
e greater than in delta receptor affinities so that all of the analogues te
sted exhibited significantly greater delta receptor selectivity than the un
substituted parent peptides. Of the target peptides tested, only N,N-dibenz
yl[Phe(p-NCS)(4)]leucine enkephalin (2) exhibited wash-resistant inhibition
of radioligand binding to delta receptors. To our knowledge, 2 represents
the first peptide-based affinity label to utilize an isothiocyanate group a
s the electrophilic affinity labeling moiety. As a result of this study, en
kephalin analogue 2 emerges as a potential affinity label useful for the fu
rther study of delta opioid receptors.